1536. Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool for Diverse Populations and Healthcare Providers
Davis W, Mantsios A, Metzner A, Talan A, Kwait J, Rodriguez H, Karver T, Barker S, Suarez A, Fernandez R, Rodriguez-Diaz C, Taggart T, Oglesby A, Garris C, Wohl D, Barrington C, Kerrigan D. 1536. Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool for Diverse Populations and Healthcare Providers. Open Forum Infectious Diseases 2023, 10: ofad500.1371. PMCID: PMC10677220, DOI: 10.1093/ofid/ofad500.1371.Peer-Reviewed Original ResearchPre-exposure prophylaxisHealthcare providersLA PrEPInjectable pre-exposure prophylaxisHIV pre-exposure prophylaxisExit interviewsPrEP conversationsClinic visitsPrEP knowledgePrEP useClinical visitsViiV HealthcarePrEP usersHIV preventionSide effectsFDA approvalCare optionsPrEPAcceptable deliveryKnowledge deficitsFormative researchProphylaxisVisitsMinor suggestionsDiverse populations
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply